Verdence Capital Advisors LLC Illumina, Inc. Transaction History

Verdence Capital Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$101.05 - $133.57 $5,860 - $7,747	-58 Reduced 1.94%	2,938 $306,000
Q1 2024 Apr 25, 2024	BUY	$127.73 - $147.2 $382,679 - $441,011	2,996 New	2,996 $411,000
Q3 2023 Oct 25, 2023	BUY	$128.91 - $192.44 $32,227 - $48,110	250 Added 9.28%	2,945 $404,000
Q2 2023 Jul 28, 2023	SELL	$183.43 - $232.67 $67,502 - $85,622	-368 Reduced 12.01%	2,695 $505,000
Q1 2023 Apr 24, 2023	BUY	$193.75 - $232.55 $593,456 - $712,300	3,063 New	3,063 $712,000
Q3 2022 Nov 15, 2022	BUY	$177.23 - $227.44 $6,380 - $8,187	36 Added 1.26%	2,889 $551,000
Q2 2022 Aug 08, 2022	BUY	$181.58 - $368.0 $153,253 - $310,592	844 Added 42.01%	2,853 $526,000
Q1 2022 May 02, 2022	BUY	$303.87 - $423.8 $424,202 - $591,624	1,396 Added 227.73%	2,009 $702,000
Q4 2021 Jan 26, 2022	SELL	$347.28 - $421.83 $212,535 - $258,159	-612 Reduced 49.96%	613 $233,000
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $132,228 - $171,097	326 Added 36.26%	1,225 $497,000
Q2 2021 Aug 06, 2021	BUY	$372.84 - $481.5 $335,183 - $432,868	899 New	899 $425,000

913

139M

1.2M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $17.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.